Mylan Looks to Sell EpiPen Directly to Public Places

Jan 10, 2017

Bloomberg

Mylan is looking to set up its own pharmacy to cut out middlemen and enable the drugmaker to sell EpiPens directly to public places, says a Bloomberg article.

Mylan wants to sell the product to public places, such as restaurants, hotels and sports venues, bypassing pharmacies and chains such as CVS and Walgreens, according to a plan obtained by Bloomberg News through public records requests.

Mylan is pursuing strategy that pushes for state laws to allow these "entity" prescriptions -- drugs sold to places rather than people -- and, if successful, could revolutionize an industry whose layers of middlemen are said to be partly responsible for higher costs faces by consumers.

Read the Bloomberg article

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments